Stevanato Group S.p.A. (STVN)
$21.06-$1.27 (-5.70%) Today
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 7 | 14,249 | $268K |
| Grant or award | 9 | 39,282 | |
| Option exercise | 8 | 29,166 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
12 Form 4 filings on record, the earliest from Jun 26, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Luciano Santel - Director | Open-market sale | Ordinary Shares | 2,023 | $20.09 | $41K | |
| Lago Marco Dal - Officer | Open-market sale | Ordinary Shares | 4,209 | $20.09 | $85K | |
| Elisabetta Magistretti - Director | Open-market sale | Ordinary Shares | 2,045 | $20.09 | $41K | |
| Madhavan Balachandran | Grant or award | Ordinary Shares | 4,975 | $0.00 | - | |
| Madhavan Balachandran | Open-market sale | Ordinary Shares | 1,493 | $17.09 | $26K | |
| Lago Marco Dal - Officer | Option exercise | Restricted Share Units | 2,924 | $0.00 | - | |
| Lago Marco Dal - Officer | Option exercise | Restricted Share Units | 2,303 | $0.00 | - | |
| Lago Marco Dal - Officer | Option exercise | Ordinary Shares | 7,997 | $0.00 | - | |
| Lago Marco Dal - Officer | Grant or award | Ordinary Shares | 2,356 | $0.00 | - | |
| Lago Marco Dal - Officer | Option exercise | Restricted Share Units | 2,770 | $0.00 | - | |
 Sue-Jean Lin | Grant or award | Ordinary Shares | 4,975 | $0.00 | - | |
| Donald E. Morel Jr. | Grant or award | Ordinary Shares | 4,975 | $0.00 | - | |
| Donald E. Morel Jr. | Open-market sale | Ordinary Shares | 1,493 | $17.09 | $26K | |
| Luciano Santel | Grant or award | Ordinary Shares | 4,975 | $0.00 | - | |
| Elisabetta Magistretti | Grant or award | Ordinary Shares | 4,975 | $0.00 | - | |
| Mauro Stocchi - Officer | Option exercise | Restricted Share Units | 2,063 | $0.00 | - | |
| Mauro Stocchi - Officer | Option exercise | Restricted Share Units | 2,053 | $0.00 | - | |
| Mauro Stocchi - Officer | Option exercise | Ordinary Shares | 6,586 | $0.00 | - | |
| Mauro Stocchi - Officer | Grant or award | Ordinary Shares | 2,101 | $0.00 | - | |
| Mauro Stocchi - Officer | Option exercise | Restricted Share Units | 2,470 | $0.00 | - | |
| Karen Flynn | Grant or award | Ordinary Shares | 4,975 | $0.00 | - | |
| Karen Flynn | Open-market sale | Ordinary Shares | 1,493 | $17.09 | $26K | |
| William J. Federici | Grant or award | Ordinary Shares | 4,975 | $0.00 | - | |
| William J. Federici | Open-market sale | Ordinary Shares | 1,493 | $17.09 | $26K |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Dal Lago Marco | Chief Financial Officer | 4,209 | $85K | View on EDGAR |
Stevanato Group S.p.A. (STVN) had 12 insider filings in the last 90 days, with the most recent on 2026-08-10. The full record for STVN runs to 12 Form 4 filings, the earliest from 2026-06-26. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of STVN were filed in the last 90 days.
7 insider sales of STVN were filed in the last 90 days, totaling $268K.
This page tracks STVN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add STVN to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
